Shay Shemesh Nuvectis Pharma, Inc. (NVCT) insider trading activity

Shay Shemesh is Chief Dev. & Ops. Officer of Nuvectis Pharma, Inc.. Currently has a direct ownership of 1.64 Million shares of NVCT, which is worth approximately $9.02 Million. The most recent transaction as insider was on Jan 02, 2025, when has been sold 150,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.64M

10.05% 3M change

10.13% 12M change

Total Value Held $9.02 Million

Shay Shemesh Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 02 2025	BUY Grant, award, or other acquisition	-	150,000 Added 8.37%	1,643,068 Common Stock
May 10 2024	BUY Open market or private purchase	$7,034 $6.32 p/Share	1,113 Added 0.07%	1,493,068 Common Stock
Jan 03 2024	BUY Grant, award, or other acquisition	-	130,000 Added 8.02%	1,491,955 Common Stock
Mar 21 2023	BUY Open market or private purchase	$5,035 $11.99 p/Share	420 Added 0.03%	1,361,955 Common Stock
Mar 15 2023	BUY Open market or private purchase	$7,175 $10.71 p/Share	670 Added 0.05%	1,361,535 Common Stock
Jan 12 2023	BUY Grant, award, or other acquisition	-	115,000 Added 7.79%	1,360,865 Common Stock
Dec 21 2022	BUY Open market or private purchase	$3,825 $7.65 p/Share	500 Added 0.04%	1,245,865 Common Stock
Nov 17 2022	BUY Open market or private purchase	$1,080 $7.2 p/Share	150 Added 0.01%	1,245,365 Common Stock
Nov 16 2022	BUY Open market or private purchase	$1,065 $7.1 p/Share	150 Added 0.01%	1,245,215 Common Stock
Sep 23 2022	BUY Open market or private purchase	$1,731 $7.87 p/Share	220 Added 0.02%	1,245,065 Common Stock
Sep 02 2022	BUY Open market or private purchase	$3,357 $8.31 p/Share	404 Added 0.03%	1,244,845 Common Stock
Sep 01 2022	BUY Open market or private purchase	$12,347 $8.07 p/Share	1,530 Added 0.12%	1,244,441 Common Stock
Aug 31 2022	BUY Open market or private purchase	$11,911 $8.07 p/Share	1,476 Added 0.12%	1,242,911 Common Stock
May 20 2022	BUY Open market or private purchase	$4,962 $16.54 p/Share	300 Added 0.02%	1,241,435 Common Stock
May 17 2022	BUY Open market or private purchase	$2,776 $19.55 p/Share	142 Added 0.01%	1,241,135 Common Stock
May 16 2022	BUY Open market or private purchase	$1,928 $19.28 p/Share	100 Added 0.01%	1,240,993 Common Stock
May 12 2022	BUY Open market or private purchase	$20,039 $15.68 p/Share	1,278 Added 0.1%	1,240,893 Common Stock
Apr 01 2022	BUY Grant, award, or other acquisition	-	60,000 Added 4.62%	1,239,615 Common Stock
Feb 07 2022	BUY Open market or private purchase	$2,936 $3.47 p/Share	846 Added 0.07%	1,179,615 Common Stock, par valu...
Feb 04 2022	BUY Open market or private purchase	$7,098 $3.38 p/Share	2,100 Added 0.18%	1,178,769 Common Stock, par valu...

Shay Shemesh

Chief Dev. & Ops. Officer

Fort Lee, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NVCT shares.

Notify only if

Value

Insider Trading

Get notified when an Nuvectis Pharma, Inc. insider buys or sells NVCT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Nuvectis Pharma, Inc.

Track Activities on NVCT

Account